These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8102526)

  • 1. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
    Selvaggini C; De Gioia L; Cantù L; Ghibaudi E; Diomede L; Passerini F; Forloni G; Bugiani O; Tagliavini F; Salmona M
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1380-6. PubMed ID: 8102526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
    De Gioia L; Selvaggini C; Ghibaudi E; Diomede L; Bugiani O; Forloni G; Tagliavini F; Salmona M
    J Biol Chem; 1994 Mar; 269(11):7859-62. PubMed ID: 7907586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.
    Kaneko K; Peretz D; Pan KM; Blochberger TC; Wille H; Gabizon R; Griffith OH; Cohen FE; Baldwin MA; Prusiner SB
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11160-4. PubMed ID: 7479957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
    Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
    J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prion peptide structure and aggregation in toxicity and membrane binding.
    Rymer DL; Good TA
    J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
    Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
    Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
    Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
    Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
    Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular properties of complexes formed between the prion protein and synthetic peptides.
    Kaneko K; Wille H; Mehlhorn I; Zhang H; Ball H; Cohen FE; Baldwin MA; Prusiner SB
    J Mol Biol; 1997 Jul; 270(4):574-86. PubMed ID: 9245588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro.
    Tagliavini F; Prelli F; Verga L; Giaccone G; Sarma R; Gorevic P; Ghetti B; Passerini F; Ghibaudi E; Forloni G
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9678-82. PubMed ID: 8105481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
    Hornemann S; Glockshuber R
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural properties of Gerstmann-Straussler-Scheinker disease amyloid protein.
    Salmona M; Morbin M; Massignan T; Colombo L; Mazzoleni G; Capobianco R; Diomede L; Thaler F; Mollica L; Musco G; Kourie JJ; Bugiani O; Sharma D; Inouye H; Kirschner DA; Forloni G; Tagliavini F
    J Biol Chem; 2003 Nov; 278(48):48146-53. PubMed ID: 12970341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathway complexity of prion protein assembly into amyloid.
    Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
    J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
    Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
    Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
    Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
    J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.